Stanford specialists discuss how the source of a person's pain can affect what they feel, and the connection between chronic pain and psychological factors.
People with a mutation in an enzyme that breaks down alcohol may be at a higher risk for developing Alzheimer's disease, new research suggests.
How does a backache translate into such an uncomfortable sensation? And why does some pain go on and on? Stanford pain medicine specialists provide answers.
Stanford researchers have teased apart the addictive and pro-social effects of MDMA -- suggesting the possibliity of a non-addictive therapy.
Stanford study show the levels of cholesterol and fat in an infant’s blood can predict that child’s social and emotional development.
In this episode of "The Future of Everything," host Russ Altman and guest Ross Shachter discuss how AI can help radiologists with diagnosis accuracy.
Surgeon Irene Wapnir and her colleagues developed a new technique for creating biological breast implants for women who have undergone a mastectomy.
Stanford Medicine researchers discuss prevention efforts and the importance of addressing the long-term health of people living with HIV.
PSA testing is an important tool to spot prostate cancer, but it remains a bit confusing. Stanford urologist James Brooks clarifies some misconceptions.
Counselor Mary Foston-English offers tips for managing relationships and maintaining peace when stress accompanies holiday celebrations.
Pediatrics professor Bonnie Halpern-Felsher shares her research on teens' perceptions of e-cigarettes and their health risks.
The care Bethel Tan received at Stanford Hospital after surgery to treat moyamoya disease inspired her to pursue a career in nursing.
Screening more than 9,000 pairs of drugs helped Stanford and NIH scientists identify two drugs that synergize against a deadly childhood brain tumor.
A new cystic fibrosis test could provide a more accurate, and easier, way to test newborns for the hereditary, lung-clogging disease.
Patients who receive prescriptions for both opioids and benzodiazepines are more likely to use opioids long term, Stanford researchers have found.
Since the Second Opinion program launched a year ago, 2,000 patients have used the service to have their medical records reviewed by a Stanford physician.